link
Bookmarks
Prostaglandins
Nathan D. Cecava, MD
To access 4,300 diagnoses written by the world's leading experts in radiology.Try it free - 15 days
0
0
0
0

KEY FACTS

  • Imaging

    • Top Differential Diagnoses

      • Pathology

        • Clinical Issues

          Selected References

          1. Celona A et al: Cortical hyperostosis after long-lasting prostaglandin E1 treatment in a newborn with complex congenital heart disease. J Pediatr. 226:302-3, 2020
          2. Akkinapally S et al: Prostaglandin E1 for maintaining ductal patency in neonates with ductal-dependent cardiac lesions. Cochrane Database Syst Rev. 2:CD011417, 2018
          3. Sidhu HS et al: Imaging features of therapeutic drug-induced musculoskeletal abnormalities. Radiographics. 32(1):105-27, 2012
          4. de Almeida JF et al: Cortical hyperostosis secondary to prolonged use of prostaglandin E1. Clinics (Sao Paulo). 62(3):363-6, 2007
          5. Velaphi S et al: Cortical hyperostosis in an infant on prolonged prostaglandin infusion: case report and literature review. J Perinatol. 24(4):263-5, 2004
          6. Lawson J: Drug-induced metabolic bone disorders. Semin Musculoskelet Radiol. 6(4):285-97, 2002
          7. Poznanski AK et al: Bone changes from prostaglandin therapy. Skeletal Radiol. 14(1):20-5, 1985
          Related Anatomy
          Loading...
          Related Differential Diagnoses
          Loading...
          References
          Tables

          Tables

          KEY FACTS

          • Imaging

            • Top Differential Diagnoses

              • Pathology

                • Clinical Issues

                  Selected References

                  1. Celona A et al: Cortical hyperostosis after long-lasting prostaglandin E1 treatment in a newborn with complex congenital heart disease. J Pediatr. 226:302-3, 2020
                  2. Akkinapally S et al: Prostaglandin E1 for maintaining ductal patency in neonates with ductal-dependent cardiac lesions. Cochrane Database Syst Rev. 2:CD011417, 2018
                  3. Sidhu HS et al: Imaging features of therapeutic drug-induced musculoskeletal abnormalities. Radiographics. 32(1):105-27, 2012
                  4. de Almeida JF et al: Cortical hyperostosis secondary to prolonged use of prostaglandin E1. Clinics (Sao Paulo). 62(3):363-6, 2007
                  5. Velaphi S et al: Cortical hyperostosis in an infant on prolonged prostaglandin infusion: case report and literature review. J Perinatol. 24(4):263-5, 2004
                  6. Lawson J: Drug-induced metabolic bone disorders. Semin Musculoskelet Radiol. 6(4):285-97, 2002
                  7. Poznanski AK et al: Bone changes from prostaglandin therapy. Skeletal Radiol. 14(1):20-5, 1985